Summary
Advanced Micro Devices Inc. (AMD) has filed an 8-K report detailing the completion of a significant acquisition. On March 30, 2025, AMD finalized the purchase, issuing approximately 8.3 million shares of its common stock and paying $3.375 billion in cash as initial consideration. Additionally, the company may issue up to 740,961 more shares and pay an additional $300 million in cash as contingent consideration, subject to certain conditions being met post-closing. This transaction marks a substantial expansion for AMD, the details of which were originally outlined in a purchase agreement filed in August 2024. The report also addresses financial obligations related to the acquired entity, ZT. ZT has an existing asset-based revolving credit facility of up to $641.7 million maturing in December 2026, with no current borrowings. AMD is providing an unsecured parent guarantee for ZT's obligations under this credit agreement, which is secured by ZT's assets (excluding intellectual property). Furthermore, ZT has an uncommitted receivables purchase facility with a limit of $850 million, which remains in place post-acquisition. No receivables are currently outstanding under this facility.
Key Highlights
- 1AMD completed a significant acquisition on March 30, 2025, involving the issuance of approximately 8.3 million shares and $3.375 billion in cash.
- 2Potential for additional consideration, up to 740,961 shares and $300 million in cash, contingent upon meeting certain conditions.
- 3The acquired entity, ZT, has an existing revolving credit facility of up to $641.7 million, currently undrawn.
- 4AMD is providing an unsecured parent guarantee for ZT's obligations under the credit facility.
- 5ZT maintains an uncommitted receivables purchase facility of $850 million, which continues post-acquisition.
- 6Shares issued as consideration were done so under exemptions from registration, relying on provisions of the Securities Act of 1933.
- 7AMD announced the closing of the transaction via a press release filed as an exhibit.